ISTANBUL escrs
Visit Booth: 136

Topcon Europe Medical BV

Website address: www.topcon-medical.eu

Company contacts: Topcon Europe Medical BV
Essebaan 11
2908 LJ Capelle aan den IJssel, The Netherlands
T +31 (0)10 458 50 77
E-mail: medical@topcon.eu



Visit Booth: 135

Tomey GmbH

Website address: www.tomey.de

Company contacts: Tomey GmbH
Am Weichselgarten 19a
91058 Erlangen
Germany
Tel. +49 9131 77710
Fax +49 9131 777120
info@tomey.de

A/B Scan-Biometer
A/B Scanner
Pachymeter
A-Scan/Biometer
Pachy+Biometer
Corneal Topography
Electrophysiology
AutoLensmeter
Autorefractor
AutoRefractorKeratometer
Endothelium Specular Microscope
Slitlamps
Phoropter
Perimeter
Chartprojector
Non-Contact Tonometer
Video Centering System
Topo.Ref-Keratometer
Chart Panel

Visit Booth: 132

THEA

Website address: www.laboratoires-thea.com

Company contacts: Onsite contact: Aycin YONETSEL (Théa Pharma Turkey)
Tel: +90 (212) 310 80 20
Email: A.Yonetsel@theapharma.com.tr

Aprokam® (cefuroxime 50 mg powder) - The first and only licensed intracameral cefuroxime
Azyter® (azithromycin 1.5%) - The first 3-day ocular antibiotic. Now approved for newborns
Mydriasert® - An innovative insert combining phenylephrine (5.4 mg) and tropicamide (0.28 mg) for an effective and stable mydriasis in 1 step

Visit Booth: 120

TearScience

Website address: www.tearscience.com

Company contacts: Ana Burns
Email: ABurns@tearscience.com
Tel: +1 919 459-4803

LipiView® is the only instrument that measures the lipid layer thickness to determine lipid deficiency caused by Meibomian Gland Dysfunction (MGD). LipiFlow® is the only FDA-cleared treatment for MGD, the chronic disease experienced by 90% of all dry eye patients, shown to restore gland function.

Visit Booth: 124

TearLab Corp

Website address: www.tearlab.com

Company contacts: TearLab
2 Clarendon Terrace
High St, Stockbridge
HANTS, UK

Tel: +44(0)1264 811081

TearLab® Corporation (www.tearlab.com) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care.